Skip to main content

Ryzneuta Disease Interactions

There is 1 disease interaction with Ryzneuta (efbemalenograstim alfa).

Moderate

Efbemalenograstim alfa-vuxw (applies to Ryzneuta) sickle cell disorders

Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Sickle Cell Anemia

Efbemalenograstim alfa-vuxw may cause severe and potentially fatal sickle cell crisis in patients with sickle cell disorders. If sickle cell crisis occurs, discontinue Efbemalenograstim alfa-vuxw.

References (1)
  1. (2023) "Product Information. Ryzneuta Prefilled Syringe (efbemalenograstim alfa)." Evive Biotech

Switch to consumer interaction data

Ryzneuta drug interactions

There are 178 drug interactions with Ryzneuta (efbemalenograstim alfa).


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.